OTOMAR
Commercial- Indications
- ENT disorders, Nasal care
Company intelligence / Profile preview
Gabri Labs
Dover, Delaware, United Statesgabrilabs.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Gabri Labs produces medical devices and over-the-counter products focused on ENT and dermatology therapeutic areas. Their Dubai facility was planned to produce up to 12 million units per year with further expansions planned by 2023.
- Therapeutic areas
- OtherDermatology
- Modalities
- Medical devicesOver-the-counter products
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Dubai Science Park
Beyond the preview
Go deeper on Gabri Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gabri Labs.